Search Results for: label/rapamycin

economic impactThe discoverer of Rapamycin treated himself with Rapamycin to delay his own death from cancer

No Comments
In 1999, the U.S. Food and Drug Administration approved rapamycin as a drug for transplant patients. Sehgal died a few years after the FDA approval, too soon to see his brainchild save the lives of thousands of transplant patients and …